Antibiotic exposure leads to massive selective pressures that initiate the emergence and spread of antibiotic resistance in commensal and pathogenic bacteria. The slow process of developing new antibiotics makes this approach counterintuitive for combatting the rapid emergence of new antibiotic resistant pathogens. Therefore, alternative approaches such as, the development of nucleic acid-based anti-bacterial treatments, anti-bacterial peptides, bacteriocins, anti-virulence compounds and bacteriophage therapies should be exploited to cope infections caused by resistant superbugs. In this editorial, we discuss how the newly popular CRISPR-Cas system has been applied to combat antibiotic resistance.
Aslam, B., Rasool, M., Idris, A., Muzammil, S., Alvi, R. F., Khurshid, M., … Baloch, Z. (2020, August 10). CRISPR-Cas system: A potential alternative tool to cope antibiotic resistance. Antimicrobial Resistance and Infection Control. BioMed Central Ltd. https://doi.org/10.1186/s13756-020-00795-6